tiprankstipranks
CanSino Biologics’ Resolutions Passed at AGM
Company Announcements

CanSino Biologics’ Resolutions Passed at AGM

CanSino Biologics, Inc. Class H (HK:6185) has released an update.

Don't Miss our Black Friday Offers:

CanSino Biologics, Inc. successfully held its 2023 Annual General Meeting (AGM) with all proposed resolutions passed by poll, including the election of Mr. Chi Shing LI as the new non-executive Director of the Board. The AGM saw a healthy turnout with over 34% of share capital represented. The company confirms full compliance with voting regulations, with no shareholders required to abstain or vote against the resolutions.

For further insights into HK:6185 stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks HongKong Auto-Generated NewsdeskCanSino Biologics Advances with New Hib Vaccine Trial
TipRanks HongKong Auto-Generated NewsdeskCanSino Biologics Sees Revenue Surge but Faces Net Losses
TipRanks HongKong Auto-Generated NewsdeskCanSino Biologics Advances Polio Vaccine with New Grant
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App